hydroxyproline has been researched along with Ache in 45 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate, an aminobisphosphonate, has been shown to lower the risk of skeletal complications associated with lytic bone lesions for up to 1 year in women with stage IV breast cancer who received chemotherapy." | 9.08 | Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. ( Blayney, D; Heffernan, M; Hortobagyi, GN; Knight, RD; Lipton, A; Mellars, K; Porter, L; Reitsma, DJ; Seaman, JJ; Simeone, JF; Sinoff, C; Theriault, RL; Wheeler, H, 1998) |
| " Pamidronate disodium, a bisphosphonate, may prove helpful in the palliative treatment of bone metastases in patients with breast cancer as demonstrated in this multicenter, dose-ranging trial." | 9.07 | Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study. ( Browning, S; Fram, RJ; George, S; Glover, D; Keller, A; Lipton, A; Macerata, RS; Miller, AA; Seaman, JJ; Zelenakas, K, 1994) |
| " It can promote PU alleviation and hydroxyproline secretion in the wound and inhibit pain and inflammatory reactions, which is worthy of clinical promotion." | 8.12 | Efficacy of Human-Recombinant Epidermal Growth Factor Combined with Povidone-Iodine for Pressure Ulcers and Its Influence on Inflammatory Cytokines. ( Lv, D; Wang, X; Yong, L; Zhang, B; Zhang, R; Zhao, Z, 2022) |
| "Sixteen patients with painful Paget's disease of the bone were treated with high doses of ascorbic acid." | 7.66 | Ascorbic acid therapy for the relief of bone pain in Paget's disease. ( Basu, TK; Donaldson, D; Gillett, MB; Hicklin, JA; Jordan, SJ; Smethurst, M; Williams, DC, 1978) |
| "Pamidronate, an aminobisphosphonate, has been shown to lower the risk of skeletal complications associated with lytic bone lesions for up to 1 year in women with stage IV breast cancer who received chemotherapy." | 5.08 | Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. ( Blayney, D; Heffernan, M; Hortobagyi, GN; Knight, RD; Lipton, A; Mellars, K; Porter, L; Reitsma, DJ; Seaman, JJ; Simeone, JF; Sinoff, C; Theriault, RL; Wheeler, H, 1998) |
| " Pamidronate disodium, a bisphosphonate, may prove helpful in the palliative treatment of bone metastases in patients with breast cancer as demonstrated in this multicenter, dose-ranging trial." | 5.07 | Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study. ( Browning, S; Fram, RJ; George, S; Glover, D; Keller, A; Lipton, A; Macerata, RS; Miller, AA; Seaman, JJ; Zelenakas, K, 1994) |
| " The trials had been conducted to assess the symptomatic effect of diacerhein, avocado/soya unsaponifiable chondrontin sulfate and oxaceprolin given for osteoarthritis of the hip or knee." | 4.80 | [Assessment of the placebo effect of symptomatic slow-acting anti-arthritics]. ( Bouvenot, G; Villani, P, 1998) |
| " It can promote PU alleviation and hydroxyproline secretion in the wound and inhibit pain and inflammatory reactions, which is worthy of clinical promotion." | 4.12 | Efficacy of Human-Recombinant Epidermal Growth Factor Combined with Povidone-Iodine for Pressure Ulcers and Its Influence on Inflammatory Cytokines. ( Lv, D; Wang, X; Yong, L; Zhang, B; Zhang, R; Zhao, Z, 2022) |
| "Sixteen patients with painful Paget's disease of the bone were treated with high doses of ascorbic acid." | 3.66 | Ascorbic acid therapy for the relief of bone pain in Paget's disease. ( Basu, TK; Donaldson, D; Gillett, MB; Hicklin, JA; Jordan, SJ; Smethurst, M; Williams, DC, 1978) |
| " Surface electromyograms were used to evaluate the muscle spasm theory; the possibility of actual muscle cell damage was monitored by the presence of myoglobinuria, while the ratio of hydroxyproline/creatinine (OHP/Cr) in 24 hr urine collection was used as a marker for connective tissue involvement." | 3.65 | Factors in delayed muscle soreness. ( Abraham, WM, 1977) |
| "A rapid and significant suppression of bone resorption was observed in all patients after intravenous treatment." | 2.69 | Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton. ( Hamdy, NA; Lycklama à Nijeholt, AA; Papapoulos, SE; Pelger, RC; Zwinderman, AH, 1998) |
| "Carbocalcitonin spray administered for 12 months at a daily dosage of 80 U MRC according to five schedules has been tested on 150 normal spontaneous postmenopausal women for its influence on bone mineral density (BMD), bone metabolism and osteoarticular pain." | 2.68 | Effects of cyclic therapy with intranasal carbocalcitonin in healthy spontaneous postmenopausal women. ( Abbruzzese, AD; Bottiglioni, F; Campobasso, C; De Aloysio, D; Mauloni, M; Pansini, F; Zanotti, L, 1996) |
| "Pamidronate is a safe, welltolerated, and effective treatment for Paget's disease." | 2.68 | Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. ( Bhagat, CI; Gutteridge, DH; Kent, GN; Nicholson, GC; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Thompson, RI; Ward, LC, 1996) |
| "Pamidronate is a second generation bisphosphonate that has been used in Europe for the treatment of Paget's disease of bone for several years." | 2.67 | Effects of intravenous pamidronate therapy on Paget's disease of bone. ( Bombassei, GJ; Raisz, LG; Yocono, M, 1994) |
| " We have evaluated the effectiveness of three dosage regimes of aminohydroxypropylidene bisphosphonate (pamidronate) in 15 patients with extensive Paget's disease who had become refractory to conventional therapy." | 2.67 | Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. ( Gunasekera, RD; Wimalawansa, SJ, 1993) |
| "Pain was rated daily on a 10-point scale by the same observers." | 2.67 | Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study. ( Karachalios, T; Lyritis, GP; Magiasis, B; Tsakalakos, N; Tsekoura, M; Yiatzides, A, 1991) |
| "We studied 21 women with postmenopausal osteoporosis, treated with salmon calcitonin nasal spray (100 IU/daily) and calcium (1 g/daily) for six months." | 1.29 | Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns. ( Montemagno, U; Riccio, S; Romano, L; Ronsini, S; Tolino, A, 1993) |
| "Paget's disease of bone in 51 patients was treated with ethane-1, hydroxy-1,1 diphosphonate (EHDP) for six months at a dosage of 5 mg/kg/day." | 1.27 | Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day). ( Alexandre, CM; Chapuy, MC; Edouard, C; Johnston, CC; Meunier, PJ; Vignon, E, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (55.56) | 18.7374 |
| 1990's | 17 (37.78) | 18.2507 |
| 2000's | 1 (2.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (4.44) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Z | 1 |
| Lv, D | 1 |
| Zhang, B | 1 |
| Yong, L | 1 |
| Zhang, R | 1 |
| Wang, X | 1 |
| Alaqeel, M | 1 |
| Grant, MP | 1 |
| Epure, LM | 1 |
| Salem, O | 1 |
| AlShaer, A | 1 |
| Huk, OL | 1 |
| Bergeron, SG | 1 |
| Zukor, DJ | 1 |
| Kc, R | 1 |
| Im, HJ | 1 |
| Anbazhagan, AN | 1 |
| Antoniou, J | 1 |
| Mwale, F | 1 |
| Alexandre, CM | 1 |
| Chapuy, MC | 1 |
| Vignon, E | 1 |
| Edouard, C | 1 |
| Johnston, CC | 3 |
| Meunier, PJ | 2 |
| Douglas, DL | 1 |
| Duckworth, T | 1 |
| Kanis, JA | 1 |
| Preston, C | 1 |
| Beard, DJ | 1 |
| Smith, TW | 1 |
| Underwood, I | 1 |
| Woodhead, JS | 1 |
| Russell, RG | 1 |
| Siris, ES | 2 |
| Canfield, RE | 2 |
| Jacobs, TP | 2 |
| Baquiran, DC | 1 |
| Kasamatsu, T | 1 |
| Miyashita, K | 1 |
| Shiomi, S | 1 |
| Iwata, H | 1 |
| Adamo, V | 1 |
| Altavilla, G | 1 |
| La Torre, F | 1 |
| Palmara, D | 1 |
| Tropea, F | 1 |
| Glover, D | 1 |
| Lipton, A | 2 |
| Keller, A | 1 |
| Miller, AA | 1 |
| Browning, S | 1 |
| Fram, RJ | 1 |
| George, S | 1 |
| Zelenakas, K | 1 |
| Macerata, RS | 1 |
| Seaman, JJ | 2 |
| Chakravarty, K | 1 |
| Merry, P | 1 |
| Scott, DG | 1 |
| Liens, D | 1 |
| Delmas, PD | 1 |
| Bombassei, GJ | 1 |
| Yocono, M | 1 |
| Raisz, LG | 1 |
| Wimalawansa, SJ | 1 |
| Gunasekera, RD | 1 |
| Tolino, A | 1 |
| Romano, L | 1 |
| Ronsini, S | 1 |
| Riccio, S | 1 |
| Montemagno, U | 1 |
| Roux, C | 1 |
| De Aloysio, D | 1 |
| Pansini, F | 1 |
| Campobasso, C | 1 |
| Zanotti, L | 1 |
| Abbruzzese, AD | 1 |
| Mauloni, M | 1 |
| Bottiglioni, F | 1 |
| Gutteridge, DH | 1 |
| Retallack, RW | 1 |
| Ward, LC | 1 |
| Stuckey, BG | 1 |
| Stewart, GO | 1 |
| Prince, RL | 1 |
| Kent, GN | 1 |
| Bhagat, CI | 1 |
| Price, RI | 1 |
| Thompson, RI | 1 |
| Nicholson, GC | 1 |
| Combe, B | 1 |
| Cohen, C | 1 |
| Aubin, F | 1 |
| Pelger, RC | 1 |
| Hamdy, NA | 1 |
| Zwinderman, AH | 1 |
| Lycklama à Nijeholt, AA | 1 |
| Papapoulos, SE | 1 |
| Hortobagyi, GN | 1 |
| Theriault, RL | 1 |
| Porter, L | 1 |
| Blayney, D | 1 |
| Sinoff, C | 1 |
| Wheeler, H | 1 |
| Simeone, JF | 1 |
| Knight, RD | 1 |
| Heffernan, M | 1 |
| Mellars, K | 1 |
| Reitsma, DJ | 1 |
| Villani, P | 1 |
| Bouvenot, G | 1 |
| Chlebna-Sokół, D | 1 |
| Jakubowska, E | 1 |
| Sikora, A | 1 |
| Motin, IuK | 1 |
| Osadchuk, MA | 1 |
| Furmanchuk, IK | 1 |
| Genzheev, VD | 1 |
| Kulidzhanov, AIu | 1 |
| Ibbertson, HK | 1 |
| Fraser, TR | 1 |
| Scott, DJ | 1 |
| Cullen, JC | 1 |
| Henley, JW | 1 |
| Stephens, ES | 1 |
| Tait, B | 1 |
| Wattie, DJ | 1 |
| Rashid, M | 1 |
| Khairi, A | 1 |
| Johnston, C | 1 |
| Khairi, MR | 2 |
| Altman, RD | 2 |
| DeRosa, GP | 1 |
| Zimmermann, J | 1 |
| Schenk, RK | 1 |
| Basu, TK | 1 |
| Smethurst, M | 1 |
| Gillett, MB | 1 |
| Donaldson, D | 1 |
| Jordan, SJ | 1 |
| Williams, DC | 1 |
| Hicklin, JA | 1 |
| Abraham, WM | 1 |
| Singer, FR | 1 |
| Doury, P | 1 |
| Delahaye, RP | 1 |
| Leguay, G | 1 |
| Pattin, S | 1 |
| Metges, PJ | 1 |
| Montely, JM | 1 |
| Duret, JC | 1 |
| Salhi, A | 1 |
| Bouvier, M | 1 |
| Lejeune, E | 1 |
| Daumont, R | 1 |
| Deplante, JP | 1 |
| Agnusdei, D | 1 |
| Camporeale, A | 1 |
| Gonnelli, S | 1 |
| Gennari, C | 1 |
| Baroni, MC | 1 |
| Passeri, M | 1 |
| Ryan, PJ | 1 |
| Gibson, T | 1 |
| Fogelman, I | 1 |
| Lyritis, GP | 1 |
| Tsakalakos, N | 1 |
| Magiasis, B | 1 |
| Karachalios, T | 1 |
| Yiatzides, A | 1 |
| Tsekoura, M | 1 |
| Attardo-Parrinello, G | 1 |
| Merlini, G | 1 |
| Pavesi, F | 1 |
| Crema, F | 1 |
| Fiorentini, ML | 1 |
| Ascari, E | 1 |
| Horswill, CA | 1 |
| Layman, DK | 1 |
| Boileau, RA | 1 |
| Williams, BT | 1 |
| Massey, BH | 1 |
| Han, C | 1 |
| Serdengeçti, S | 1 |
| Serdengeçti, K | 1 |
| Derman, U | 1 |
| Berkarda, B | 1 |
| Morales Piga, A | 1 |
| García Vadillo, A | 1 |
| Rodríguez García, A | 1 |
| Elena Ibáñez, A | 1 |
| Castro Beiras, JM | 1 |
| Rodríguez Torrás, M | 1 |
| Wellman, H | 1 |
| Serafini, AN | 1 |
| Sankey, RR | 1 |
| Ryan, WG | 1 |
| Schwartz, TB | 1 |
| Northrop, G | 1 |
| Elias, EG | 1 |
| Evans, JT | 1 |
| Christiansen, C | 1 |
| Tonnesen, KH | 1 |
| Hioco, D | 1 |
| Denis, F | 1 |
| Brodaty, I | 1 |
| de Sèze, S | 1 |
| Hamilton, CR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome[NCT00001728] | Phase 2 | 40 participants (Actual) | Interventional | 1998-08-24 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydroxyproline and Ache
| Article | Year |
|---|---|
[Assessment of the placebo effect of symptomatic slow-acting anti-arthritics].
Topics: Activities of Daily Living; Aged; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Antirheum | 1998 |
Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Deafness; Etidronic Acid; Fractures, Bone | 1977 |
18 trials available for hydroxyproline and Ache
| Article | Year |
|---|---|
Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Analgesics, Opioid; Bone Neoplasms; Bre | 1994 |
A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Child; Creatinine; Diphosphonates; Female; Humans; Hy | 1994 |
Effects of intravenous pamidronate therapy on Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Diphosphonates; Female; Humans; Hydroxyproli | 1994 |
Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Topics: Alkaline Phosphatase; Calcitonin; Creatinine; Diphosphonates; Drug Administration Schedule; Drug Res | 1993 |
The methodology of clinical trials of oral tiludronate in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Development; Creatinine; Diphosphonates; | 1995 |
Effects of cyclic therapy with intranasal carbocalcitonin in healthy spontaneous postmenopausal women.
Topics: Administration, Intranasal; Alkaline Phosphatase; Bone and Bones; Bone Density; Calcitonin; Dose-Res | 1996 |
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Bone and Bones; Diphosphonates; | 1996 |
Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin.
Topics: Administration, Intranasal; Adult; Aerosols; Aged; Aged, 80 and over; Analgesics; Calcitonin; Calciu | 1997 |
Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Agents; Bone Neo | 1998 |
Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.
Topics: Alkaline Phosphatase; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 1998 |
[Clinical observation of osteoporosis in adolescents].
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone and Bones; Bone Density; Child; Female; Humans; Hydr | 2000 |
Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Matrix; Clinical Trials as Topic; Etidronic | 1977 |
Short-term treatment of Paget's disease of bone with ipriflavone.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Creatinine; Double-Blind Method; F | 1992 |
Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study.
Topics: Aged; Analgesics; Calcitonin; Calcium; Double-Blind Method; Female; Humans; Hydroxyproline; Osteopor | 1991 |
Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Bone Ne | 1987 |
Dichloromethylene diphosphonate action in hematologic and other malignancies.
Topics: Administration, Oral; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Tr | 1987 |
Salmon calcitonin in the treatment of bone metastases.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Calcitonin; Calcium; Female; Follow-Up Studies; H | 1986 |
Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Clinical Trials as Topic; Dose-Res | 1973 |
25 other studies available for hydroxyproline and Ache
| Article | Year |
|---|---|
Efficacy of Human-Recombinant Epidermal Growth Factor Combined with Povidone-Iodine for Pressure Ulcers and Its Influence on Inflammatory Cytokines.
Topics: Cytokines; Epidermal Growth Factor; Humans; Hydroxyproline; Immunologic Factors; Inflammation; Pain; | 2022 |
Link N suppresses interleukin-1β-induced biological effects on human osteoarthritic cartilage.
Topics: Aged; Animals; Behavior, Animal; Cartilage, Articular; Chondrocytes; Collagen Type II; Disease Model | 2020 |
Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
Topics: Adult; Aged; Alkaline Phosphatase; Blood Chemical Analysis; Cell Count; Drug Evaluation; Etidronic A | 1983 |
Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Humans; Hydroxyproline; M | 1980 |
Long-term therapy of Paget's disease of bone with EHDP.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Female; Humans; Hydroxyproline; Long-Ter | 1980 |
Urinary excretion of hydroxyproline in workers occupationally exposed to vibration.
Topics: Adult; Age Factors; Creatinine; Hand; Humans; Hydroxyproline; Middle Aged; Movement; Muscles; Occupa | 1982 |
[Effects of synthetic salmon calcitonin in the treatment of bone lesions of the neoplastic type].
Topics: Adult; Aged; Alkaline Phosphatase; Animals; Bone Neoplasms; Calcitonin; Calcium; Female; Humans; Hyd | 1982 |
Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.
Topics: Adolescent; Adult; Alkaline Phosphatase; Diphosphonates; Female; Fibrous Dysplasia of Bone; Follow-U | 1994 |
Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
Topics: Absorptiometry, Photon; Administration, Inhalation; Aerosols; Bone and Bones; Calcitonin; Calcium; F | 1993 |
[Healing and relapse in duodenal bulb chronic ulcer in patients of young age].
Topics: Adolescent; Adult; Age Factors; Biomarkers; Duodenal Ulcer; Duodenoscopy; Gastric Juice; Humans; Hyd | 1991 |
Paget's disease of bone: assessment and management.
Topics: Aged; Alkaline Phosphatase; Analgesics; Calcitonin; Etidronic Acid; Humans; Hydroxyproline; Middle A | 1979 |
Ascorbic acid therapy for the relief of bone pain in Paget's disease.
Topics: Aged; Alkaline Phosphatase; Ascorbic Acid; Female; Humans; Hydroxyproline; Male; Osteitis Deformans; | 1978 |
Factors in delayed muscle soreness.
Topics: Adult; Creatinine; Electromyography; Evoked Potentials; Female; Heart Rate; Humans; Hydroxyproline; | 1977 |
Human calcitonin treatment of Paget's disease of bone.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Humans; Hydroxyproline; Osteitis Deforman | 1977 |
[Diffuse articular chondrocalcinosis and Paget's disease].
Topics: Adult; Aged; Alkaline Phosphatase; Chondrocalcinosis; Diabetes Complications; Female; Humans; Hydrox | 1975 |
[Letter: Results of treatment of Paget's disease of bone with swine thyrocalcitonin].
Topics: Alkaline Phosphatase; Body Temperature; Calcitonin; Calcium; Humans; Hydroxyproline; Osteitis Deform | 1975 |
Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
Topics: Alkaline Phosphatase; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Os | 1992 |
Excretion of 3-methylhistidine and hydroxyproline following acute weight-training exercise.
Topics: Adult; Body Weight; Female; Histidine; Humans; Hydroxyproline; Male; Methylhistidines; Muscles; Pain | 1988 |
An investigation of the effects of cadmium exposure on human health.
Topics: Adult; Cadmium; Cadmium Poisoning; Carbohydrates; China; Environmental Pollutants; Female; Hematolog | 1988 |
[Usefulness of ethane-hydroxy-diphosphonate in the treatment of Paget's disease].
Topics: Aged; Alkaline Phosphatase; Drug Evaluation; Etidronic Acid; Female; Humans; Hydroxyproline; Male; M | 1985 |
Treatment of Paget's disease with mithramycin: further experiences.
Topics: Alkaline Phosphatase; Antibiotics, Antineoplastic; Gluconates; Humans; Hydroxyproline; Hypocalcemia; | 1972 |
Mithramycin in the treatment of Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Blood Urea Nitrogen; Cardiac Output; Female | 1972 |
Zinc-protamine-glucagon in the treatment of Paget's disease of bone. Preliminary report.
Topics: Aged; Alkaline Phosphatase; Calcium; Drug Combinations; Glucagon; Humans; Hydroxyproline; Male; Oste | 1974 |
[Treatment of osteoporosis by repeated calcium infusions].
Topics: Alkaline Phosphatase; Calcium; Humans; Hydroxyproline; Injections, Intravenous; Osteoporosis; Pain; | 1973 |
Effects of synthetic salmon calcitonin in patients with Paget's disease of bone.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Animals; Calcitonin; Calcium; Female; Humans; Hydr | 1974 |